Gsa Capital Partners LLP Siga Technologies Inc Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.96 - $9.26 $94,843 - $126,186	-13,627 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.71 - $7.39 $77,810 - $100,703	13,627 New	13,627 $101,000
Q3 2020 Nov 06, 2020	SELL	$5.62 - $7.68 $142,585 - $194,849	-25,371 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$4.55 - $6.19 $307,115 - $417,812	-67,498 Reduced 72.68%	25,371 $150,000
Q1 2020 May 12, 2020	BUY	$3.99 - $5.46 $213,233 - $291,793	53,442 Added 135.55%	92,869 $444,000
Q4 2019 Feb 12, 2020	SELL	$4.34 - $5.86 $41,711 - $56,320	-9,611 Reduced 19.6%	39,427 $188,000
Q3 2019 Nov 12, 2019	SELL	$4.93 - $5.8 $17,195 - $20,230	-3,488 Reduced 6.64%	49,038 $251,000
Q2 2019 Aug 06, 2019	BUY	$5.22 - $6.1 $274,185 - $320,408	52,526 New	52,526 $298,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $432M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.